{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:32:49Z","timestamp":1707525169152},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,8]]},"DOI":"10.7759\/cureus.43126","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T11:07:02Z","timestamp":1691492822000},"source":"Crossref","is-referenced-by-count":0,"title":["A Blast From the Past: Abdominal Wall Amyloidosis Due to Enfuvirtide Injections"],"prefix":"10.7759","author":[{"given":"Cecilia","family":"Costiniuk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Marie","family":"Bourgault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chelsea","family":"Maedler-Kron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liane","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s1386-6532(03)00116-1","article-title":"Influence of subcutaneous injection site on the steady-state pharmacokinetics of enfuvirtide (T-20) in HIV-1-infected patients","volume":"28","author":"Lalezari JP","year":"2003","unstructured":"Lalezari JP, Patel IH, Zhang X, et al.. Influence of subcutaneous injection site on the steady-state pharmacokinetics of enfuvirtide (T-20) in HIV-1-infected patients. J Clin Virol. 2003, 28:217-22. 10.1016\/s1386-6532(03)00116-1","journal-title":"J Clin Virol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2013.10.029","article-title":"Insulin-derived amyloidosis and poor glycemic control: a case series","volume":"127","author":"Nagase T","year":"2014","unstructured":"Nagase T, Iwaya K, Iwaki Y, et al.. Insulin-derived amyloidosis and poor glycemic control: a case series. Am J Med. 2014, 127:450-4. 10.1016\/j.amjmed.2013.10.029","journal-title":"Am J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035211","article-title":"Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia","volume":"348","author":"Lazzarin A","year":"2003","unstructured":"Lazzarin A, Clotet B, Cooper D, et al.. Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia. N Engl J Med. 2003, 348:2186-95. 10.1056\/NEJMoa035211","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2020.1835263","article-title":"Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee","volume":"27","author":"Benson MD","year":"2020","unstructured":"Benson MD, Buxbaum JN, Eisenberg DS, et al.. Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid. 2020, 27:217-22. 10.1080\/13506129.2020.1835263","journal-title":"Amyloid"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(03)02099-1","article-title":"Injection site reactions with the HIV-1 fusion inhibitor enfuvirtide","volume":"49","author":"Ball RA","year":"2003","unstructured":"Ball RA, Kinchelow T. Injection site reactions with the HIV-1 fusion inhibitor enfuvirtide. J Am Acad Dermatol. 2003, 49:826-31. 10.1016\/s0190-9622(03)02099-1","journal-title":"J Am Acad Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh141","article-title":"Cutaneous injection site reactions to long-term therapy with enfuvirtide","volume":"53","author":"Maggi P","year":"2004","unstructured":"Maggi P, Ladisa N, Cinori E, Altobella A, Pastore G, Filotico R. Cutaneous injection site reactions to long-term therapy with enfuvirtide. J Antimicrob Chemother. 2004, 53:678-81. 10.1093\/jac\/dkh141","journal-title":"J Antimicrob Chemother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-7-200910060-00017","article-title":"Localized amyloidosis at the site of enfuvirtide injection","volume":"151","author":"Morilla ME","year":"2009","unstructured":"Morilla ME, Kocher J, Harmaty M. Localized amyloidosis at the site of enfuvirtide injection. Ann Intern Med. 2009, 151:515-6. 10.7326\/0003-4819-151-7-200910060-00017","journal-title":"Ann Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3109\/13506129.2013.876984","article-title":"Pharmaceutical amyloidosis associated with subcutaneous insulin and enfuvirtide administration","volume":"21","author":"D'Souza A","year":"2014","unstructured":"D'Souza A, Theis JD, Vrana JA, Dogan A. Pharmaceutical amyloidosis associated with subcutaneous insulin and enfuvirtide administration. Amyloid. 2014, 21:71-5. 10.3109\/13506129.2013.876984","journal-title":"Amyloid"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.2010.00717.x","article-title":"Enfuvirtide injection site reactions: a clinical and histopathological appraisal","volume":"52","author":"Wallace BJ","year":"2011","unstructured":"Wallace BJ, Tan KB, Pett SL, Cooper DA, Kossard S, Whitfeld MJ. Enfuvirtide injection site reactions: a clinical and histopathological appraisal. Australas J Dermatol. 2011, 52:19-26. 10.1111\/j.1440-0960.2010.00717.x","journal-title":"Australas J Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/cup.12501","article-title":"Nodular amyloidosis at the sites of insulin injections","volume":"42","author":"Bern\u00e1rdez C","year":"2015","unstructured":"Bern\u00e1rdez C, Sch\u00e4rer L, Molina-Ruiz AM, Requena L. Nodular amyloidosis at the sites of insulin injections. J Cutan Pathol. 2015, 42:496-502. 10.1111\/cup.12501","journal-title":"J Cutan Pathol"},{"key":"ref11","article-title":"Iatrogenic, insulin-dependent, local amyloidosis","volume":"48","author":"St\u00f6rkel S","year":"1983","unstructured":"St\u00f6rkel S, Schneider HM, M\u00fcntefering H, Kashiwagi S. Iatrogenic, insulin-dependent, local amyloidosis. Lab Invest. 1983, 48:108-11.","journal-title":"Lab Invest"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1210\/en.2010-0457","article-title":"Inhaled insulin forms toxic pulmonary amyloid aggregates","volume":"151","author":"Lasagna-Reeves CA","year":"2010","unstructured":"Lasagna-Reeves CA, Clos AL, Midoro-Hiriuti T, Goldblum RM, Jackson GR, Kayed R. Inhaled insulin forms toxic pulmonary amyloid aggregates. Endocrinology. 2010, 151:4717-24. 10.1210\/en.2010-0457","journal-title":"Endocrinology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/138679-a-blast-from-the-past-abdominal-wall-amyloidosis-due-to-enfuvirtide-injections","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:01:45Z","timestamp":1707508905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/138679-a-blast-from-the-past-abdominal-wall-amyloidosis-due-to-enfuvirtide-injections"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,8]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.43126","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,8]]}}}